Fractyl Health, Inc. Common Stock (GUTS)
USD 0.98
(3.57%)
USD 0.98
(3.57%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 342.48 Million USD | 12.26% |
| 2022 | 305.09 Million USD | 6.18% |
| 2021 | 287.33 Million USD | 46.89% |
| 2020 | 195.6 Million USD | 32.15% |
| 2019 | 148.01 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 28.69 Million USD | -91.62% |
| 2024 Q2 | 28.36 Million USD | -1.14% |
| 2023 FY | 342.48 Million USD | 12.26% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | 342.48 Million USD | 0.12% |
| 2023 Q2 | 36.37 Million USD | 0.0% |
| 2023 Q3 | 342.07 Million USD | 840.51% |
| 2022 Q4 | 305.09 Million USD | 0.0% |
| 2022 FY | 305.09 Million USD | 6.18% |
| 2021 Q3 | 291.7 Million USD | 0.0% |
| 2021 FY | 287.33 Million USD | 46.89% |
| 2021 Q4 | 287.33 Million USD | -1.5% |
| 2020 Q4 | 195.6 Million USD | 0.0% |
| 2020 FY | 195.6 Million USD | 32.15% |
| 2019 FY | 148.01 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 71.19 Million USD | -381.041% |
| Bicycle Therapeutics plc | 40.08 Million USD | -754.496% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -2960.334% |
| Aptorum Group Limited | 3.05 Million USD | -11097.711% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -1221.916% |
| CRISPR Therapeutics AG | 223 Million USD | -53.575% |
| Innoviva, Inc. | 446.23 Million USD | 23.251% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1036.417% |
| AlloVir, Inc. | 16.64 Million USD | -1957.196% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -227.396% |
| Pharming Group N.V. | 166.1 Million USD | -106.184% |
| AbCellera Biologics Inc. | 71.22 Million USD | -380.865% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -715.666% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -379911.983% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -921.877% |
| ContextLogic Inc. | 6 Million USD | -5608.033% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -345841.414% |
| Incyte Corporation | 29.16 Million USD | -1074.412% |
| Novavax, Inc. | 168.01 Million USD | -103.839% |
| Seer, Inc. | 25.96 Million USD | -1219.065% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -28298.176% |
| Summit Therapeutics Inc. | 103.29 Million USD | -231.573% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -8986.813% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -698.81% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -228.243% |
| Vaxcyte, Inc. | 22.11 Million USD | -1448.921% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -147.63% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -550.389% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -5412.345% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -894319.054% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | -149.397% |
| Acelyrin, Inc. | 1.19 Million USD | -28583.585% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -74352.609% |
| Senti Biosciences, Inc. | 33.53 Million USD | -921.176% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -467.766% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 85.383% |
| Ardelyx, Inc. | 51.54 Million USD | -564.407% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -1556636.364% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -240.446% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -420.83% |
| Chimerix, Inc. | 125 Thousand USD | -273885.6% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -10474.9% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -1204.048% |
| Precision BioSciences, Inc. | 7.72 Million USD | -4334.572% |
| Fortress Biotech, Inc. | 60.85 Million USD | -462.774% |
| Fortress Biotech, Inc. | 60.85 Million USD | -462.774% |
| IO Biotech, Inc. | 1.83 Million USD | -18523.274% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -512260.122% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -8910.313% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -30342.844% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -1005.03% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Alkermes plc | 287.73 Million USD | -19.029% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -259.792% |
| Onconetix, Inc. | 118.85 Thousand USD | -288046.26% |
| Opthea Limited | 200.53 Million USD | -70.784% |
| PDS Biotechnology Corporation | 19.5 Million USD | -1655.761% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 18.25 Million USD | -1776.614% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -1603.975% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -891.093% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -21714.14% |
| Windtree Therapeutics, Inc. | 15 Million USD | -2183.213% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -1248.142% |
| ChromaDex Corporation | 2.57 Million USD | -13200.272% |
| Dyadic International, Inc. | 88.87 Thousand USD | -385274.142% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -41014.286% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -196.573% |
| MiMedx Group, Inc. | 48.09 Million USD | -612.036% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -2448.419% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -5851.034% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -556817.523% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 5.94 Million USD | -5656.968% |
| ImmuCell Corporation | 10.54 Million USD | -3149.202% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -1387.435% |
| Precigen, Inc. | 5.89 Million USD | -5709.703% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -236094.483% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -7075.403% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -79.374% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -46687.158% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -251.769% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -65.476% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -10642.848% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -32894.412% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -1434.005% |
| Aptose Biosciences Inc. | 621 Thousand USD | -55050.081% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -33777.78% |
| Century Therapeutics, Inc. | 46.65 Million USD | -634.026% |
| Kura Oncology, Inc. | 9.33 Million USD | -3569.974% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -1182.704% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -248075.362% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -3549.249% |
| Autolus Therapeutics plc | 47.91 Million USD | -614.785% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -6880.881% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -4956.578% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -162.117% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -4125.564% |
| IGM Biosciences, Inc. | 34.67 Million USD | -887.777% |
| INmune Bio, Inc. | 397 Thousand USD | -86167.506% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -97.109% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -8347.46% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -232961.811% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -588.102% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -527.601% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -649.528% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 27.65% |
| Verastem, Inc. | 40.08 Million USD | -754.368% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -7680.145% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -3306.425% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -5119.966% |
| Histogen Inc. | 4.38 Million USD | -7712.089% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -38730.159% |
| Organovo Holdings, Inc. | 888 Thousand USD | -38467.793% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -1041.607% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -8065.999% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -1712.554% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -352.42% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -367748.857% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -1221.967% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -128170.412% |
| Amarin Corporation plc | 8.73 Million USD | -3819.904% |
| Mesoblast Limited | 100.48 Million USD | -240.836% |
| Turnstone Biologics Corp. | 1.18 Million USD | -28704.205% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -337.235% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -314103.67% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -317.615% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -80.307% |
| Better Therapeutics, Inc. | 10.34 Million USD | -3209.644% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -1381.003% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -268.13% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -26407.895% |
| Gritstone bio, Inc. | 40.14 Million USD | -753.134% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -18779.934% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -122.98% |
| Insmed Incorporated | 1.19 Billion USD | 71.301% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -5293.417% |
| OmniAb, Inc. | 22.07 Million USD | -1451.447% |
| Alector, Inc. | 30.45 Million USD | -1024.514% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -237.274% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -4156.021% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 19.717% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1930.124% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -501.965% |
| Immunic, Inc. | 639 Thousand USD | -53496.557% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -1048.536% |
| Veracyte, Inc. | 7.52 Million USD | -4451.256% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 46.891% |
| FibroGen, Inc. | 89.69 Million USD | -281.821% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -7796.749% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -261610.338% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 93.295% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -925527.027% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -17197.071% |
| TG Therapeutics, Inc. | 100.11 Million USD | -242.078% |
| Galecto, Inc. | 66 Thousand USD | -518812.121% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -251725.0% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 79.02% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -5593.799% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -6245.785% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -18779.934% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -1496.876% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -836.895% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -66144.101% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -657.101% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -1020.174% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -664.435% |
| Vaxxinity, Inc. | 13.26 Million USD | -2482.431% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 57.784% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -76167.612% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -3796.712% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 87.329% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -108280.38% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -7582.414% |
| Ainos, Inc. | 5.92 Million USD | -5683.649% |
| Pluri Inc. | 29.05 Million USD | -1078.818% |
| Prothena Corporation plc | 10.72 Million USD | -3094.497% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -1625.263% |
| Celularity Inc. | 26.17 Million USD | -1208.332% |
| Rallybio Corporation | 173 Thousand USD | -197866.474% |
| Cue Biopharma, Inc. | 4.2 Million USD | -8050.452% |
| MeiraGTx Holdings plc | 72.11 Million USD | -374.885% |
| Omeros Corporation | 329.7 Million USD | -3.875% |
| Humacyte, Inc. | 38.6 Million USD | -787.259% |
| Immunocore Holdings plc | 82.64 Million USD | -314.406% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -21132.61% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -9474.56% |
| Blueprint Medicines Corporation | 610.96 Million USD | 43.944% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -23389.849% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -603.48% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -276.764% |
| Pulmatrix, Inc. | 8.32 Million USD | -4012.91% |
| Elicio Therapeutics, Inc. | 6 Million USD | -5601.382% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -2545.67% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -253.998% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -72923.881% |
| Cytokinetics, Incorporated | 607.37 Million USD | 43.613% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -3840.198% |
| Nutriband Inc. | 79.82 Thousand USD | -428935.653% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -7537.868% |
| Vor Biopharma Inc. | 31.83 Million USD | -975.972% |
| Roivant Sciences Ltd. | 477.85 Million USD | 28.329% |
| Evogene Ltd. | 10.65 Million USD | -3114.888% |
| ProKidney Corp. | 3.61 Million USD | -9387.036% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -45022.793% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -1300826.84% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 80.268% |
| CorMedix Inc. | 517.01 Thousand USD | -66142.435% |
| BioLineRx Ltd. | 6.62 Million USD | -5067.2% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -829.698% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -377.387% |
| Atai Life Sciences N.V. | 15.21 Million USD | -2151.542% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -40556.039% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -134206.667% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -693.701% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -83297.945% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -24916.947% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -51548.698% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -92.33% |
| Biomea Fusion, Inc. | 7.83 Million USD | -4273.972% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -20.502% |
| Mereo BioPharma Group plc | 5.3 Million USD | -6361.925% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -15829.395% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -58145.238% |
| Absci Corporation | 4.66 Million USD | -7249.399% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -2872.418% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -1409.064% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -3323.108% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -2876.81% |
| Allakos Inc. | 38.21 Million USD | -796.198% |
| Imunon, Inc. | 1.13 Million USD | -29960.924% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -3868.965% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -40866.746% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -3424720.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -287.66% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -7172.924% |
| XOMA Corporation | 118.51 Million USD | -188.97% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -3301.351% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -823.655% |
| aTyr Pharma, Inc. | 13.76 Million USD | -2387.702% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -4235.764% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -1271.904% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -1595.036% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -2283113.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -123010.824% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2269.321% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 77.156% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -251405.071% |
| UroGen Pharma Ltd. | 98.55 Million USD | -247.518% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -129.678% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -1696.203% |
| Entera Bio Ltd. | 256 Thousand USD | -133682.031% |
| GH Research PLC | 631 Thousand USD | -54176.07% |
| Lisata Therapeutics, Inc. | 137.00 USD | -249986761.314% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -53246.106% |
| Xencor, Inc. | 14.64 Million USD | -2239.038% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -227839.914% |
| Replimune Group, Inc. | 71.99 Million USD | -375.736% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -228221.333% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -4788.41% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -251405.071% |
| Portage Biotech Inc. | 7000.00 USD | -4892500.0% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -51548.698% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -23866.55% |
| OncoCyte Corporation | 2.2 Million USD | -15439.111% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -511792.983% |
| Purple Biotech Ltd. | 163 Thousand USD | -210011.656% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -13410.138% |
| scPharmaceuticals Inc. | 38.81 Million USD | -782.435% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -1256.687% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -469053.425% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -18382.569% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -1199.841% |
| Curis, Inc. | 1.48 Million USD | -22900.806% |
| Daré Bioscience, Inc. | 3.91 Million USD | -8650.903% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -48986.231% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -5707933.333% |
| BeiGene, Ltd. | 197.61 Million USD | -73.305% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -37473.45% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -325.047% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -560.028% |
| bluebird bio, Inc. | 224.41 Million USD | -52.608% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 42.255% |
| DBV Technologies S.A. | 4.52 Million USD | -7466.991% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -25458.358% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -3415.52% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -8991.638% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 9.219% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -698.755% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -19846.535% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -36805.388% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -1860.737% |
| MacroGenics, Inc. | 30.19 Million USD | -1034.197% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -1834.599% |
| Prime Medicine, Inc. | 4.35 Million USD | -7760.5% |
| Aditxt, Inc. | 1.04 Million USD | -32775.831% |
| Adagene Inc. | 13.54 Million USD | -2429.403% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2393.135% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 33.974% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1903.639% |
| SciSparc Ltd. | 24 Thousand USD | -1426908.333% |
| Vericel Corporation | 81.85 Million USD | -318.396% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -317.575% |
| Generation Bio Co. | 89.77 Million USD | -281.494% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -1443.755% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -69.714% |
| Invivyd, Inc. | 722 Thousand USD | -47335.18% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -606.119% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -11713772.348% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -8853.778% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -1488952.174% |
| 2seventy bio, Inc. | 244.01 Million USD | -40.354% |
| ADMA Biologics, Inc. | 130.59 Million USD | -162.249% |
| Clene Inc. | 7.15 Million USD | -4688.619% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -10043.831% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -38.311% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -31006.449% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -130188.171% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -77.802% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -1105.795% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -3453.086% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -206.683% |
| Evaxion Biotech A/S | 8.48 Million USD | -3934.54% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -357.1% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -429.216% |
| Trevena, Inc. | 35.23 Million USD | -872.049% |
| Surrozen, Inc. | 882 Thousand USD | -38730.159% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -5409.685% |
| Cingulate Inc. | 135.09 Thousand USD | -253404.467% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -1354.956% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -616.49% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -190167.778% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -1249.47% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -1864.111% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -36489.957% |
| Statera Biopharma, Inc. | 11.43 Million USD | -2896.044% |
| ImmunityBio, Inc. | 836.95 Million USD | 59.08% |
| Korro Bio, Inc. | 31.21 Million USD | -997.136% |
| Kineta, Inc. | 150 Thousand USD | -228221.333% |
| BioVie Inc. | 349.89 Thousand USD | -97781.644% |
| Codexis, Inc. | 12.24 Million USD | -2697.37% |
| Celularity Inc. | 26.17 Million USD | -1208.332% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -620.181% |
| Celcuity Inc. | 37.03 Million USD | -824.742% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -194111.347% |
| Cibus, Inc. | 17.67 Million USD | -1837.773% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -10035.602% |
| Kodiak Sciences Inc. | 100 Million USD | -242.482% |
| Annexon, Inc. | 29.19 Million USD | -1073.285% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -429.936% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -30424.242% |
| Avalo Therapeutics, Inc. | 2 Million USD | -17024.1% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 75.544% |
| Eyenovia, Inc. | 8.95 Million USD | -3723.525% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -421.607% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -4106.362% |
| Arcellx, Inc. | 50.84 Million USD | -573.633% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -23389.849% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -1512.591% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -32362.749% |
| Moolec Science SA | 99.04 Thousand USD | -345680.748% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -1139.933% |
| Geron Corporation | 35.05 Million USD | -877.096% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -57849.577% |
| Royalty Pharma plc | 6.13 Billion USD | 94.418% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -20757.613% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1078855.327% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -1379.532% |
| Humacyte, Inc. | 38.6 Million USD | -787.259% |
| Structure Therapeutics Inc. | 4.01 Million USD | -8434.313% |
| 89bio, Inc. | 24.79 Million USD | -1281.254% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -2654.399% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -18253.805% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -33086.24% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -244.175% |
| Notable Labs, Ltd. | 1.52 Million USD | -22343.119% |
| Liquidia Corporation | 2.36 Million USD | -14387.394% |
| Mustang Bio, Inc. | 1.97 Million USD | -17214.56% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2393.135% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -4825.672% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -107938.486% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -586.653% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -3466.035% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -522861.108% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -251725.0% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -5367.465% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -263347.692% |
| PepGen Inc. | 17.1 Million USD | -1902.819% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -72153.586% |
| United Therapeutics Corporation | 300 Million USD | -14.161% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -1330.525% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -8127.1% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -59152.941% |
| XOMA Corporation | 118.51 Million USD | -188.97% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -925527.027% |
| Bionomics Limited | 117.62 Million USD | -191.157% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -36607.61% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -6004.848% |
| uniQure N.V. | 130.06 Million USD | -163.316% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -484.54% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -49824.49% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -7796.749% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -24627.942% |
| Altimmune, Inc. | 175 Thousand USD | -195604.0% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 11.699% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -6004.848% |
| Compugen Ltd. | 719 Thousand USD | -47533.102% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -6660.403% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -305.041% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -3348.963% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -5268.898% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -274.666% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -3348.963% |
| Instil Bio, Inc. | 81.42 Million USD | -320.6% |
| argenx SE | 15.35 Million USD | -2130.572% |
| Immunome, Inc. | 1.34 Million USD | -25458.358% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -63795.896% |
| Verona Pharma plc | 48.37 Million USD | -607.988% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -3616.168% |
| Shattuck Labs, Inc. | 3.4 Million USD | -9955.255% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -402820.0% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -203758.333% |
| Moolec Science SA | 99.04 Thousand USD | -345680.748% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -3004.423% |
| AnaptysBio, Inc. | 16.03 Million USD | -2035.574% |
| Design Therapeutics, Inc. | 2.33 Million USD | -14573.608% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -1265025.042% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -5608.033% |
| Achilles Therapeutics plc | 1.07 Million USD | -31729.182% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -3616.168% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -1717807.303% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1945.593% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -428935.653% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -4590196.207% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -2634376.923% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -1298.799% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -13599.335% |
| Palisade Bio, Inc. | 90 Thousand USD | -380435.556% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -176437.113% |
| Beam Therapeutics Inc. | 159.91 Million USD | -114.17% |
| Neurogene Inc. | 13.37 Million USD | -2460.996% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -11.768% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -572401.755% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -34148.2% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -745.468% |
| Athira Pharma, Inc. | 1.21 Million USD | -28041.495% |
| Vaccinex, Inc. | 26 Thousand USD | -1317138.462% |
| HCW Biologics Inc. | 6.3 Million USD | -5332.499% |
| XOMA Corporation | 118.51 Million USD | -188.97% |
| Nektar Therapeutics | 112.62 Million USD | -204.091% |
| Arvinas, Inc. | 800 Thousand USD | -42710.25% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2269.321% |
| Merus N.V. | 10.48 Million USD | -3165.465% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -2200.853% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -2450.316% |
| Rezolute, Inc. | 1.66 Million USD | -20531.446% |
| Clene Inc. | 7.15 Million USD | -4688.619% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -466827.524% |
| BeyondSpring Inc. | 3.36 Million USD | -10080.797% |
| Synlogic, Inc. | 12.49 Million USD | -2641.83% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -948.757% |
| Krystal Biotech, Inc. | 6.62 Million USD | -5073.444% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -100.377% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -5611.841% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -722878.193% |
| MannKind Corporation | 252.15 Million USD | -35.824% |
| Ikena Oncology, Inc. | 7.18 Million USD | -4669.944% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -172001.508% |
| Gossamer Bio, Inc. | 197.4 Million USD | -73.492% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -65761.923% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -21.738% |
| Mural Oncology plc | 8.91 Million USD | -3743.362% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -683.067% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -23749.721% |
| Champions Oncology, Inc. | 6.09 Million USD | -5520.909% |
| REGENXBIO Inc. | 82.22 Million USD | -316.533% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -69227.919% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -7623.996% |
| Vaxart, Inc. | 2.62 Million USD | -12956.881% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -125983.547% |
| Cellectis S.A. | 36.24 Million USD | -845.013% |
| Longeveron Inc. | 1.44 Million USD | -23552.072% |
| Repare Therapeutics Inc. | 1.01 Million USD | -33809.109% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 69.759% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -664.998% |
| Revolution Medicines, Inc. | 80.57 Million USD | -325.047% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -10575.873% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -193392.655% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -278340.65% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 52.742% |
| Denali Therapeutics Inc. | 44.98 Million USD | -661.393% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -2638.925% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -253404.467% |
| Passage Bio, Inc. | 22.92 Million USD | -1394.184% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -5571.171% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -52833.849% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -1598.398% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -69794.286% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -83953.532% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -28728.451% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -73393.991% |
| OmniAb, Inc. | 22.07 Million USD | -1451.447% |
| Anew Medical, Inc. | 1.54 Million USD | -22139.091% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -1058.6% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -3691.454% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -1001.583% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -8347.46% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -564.278% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -5279.017% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2323.965% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -50864.583% |
| Alumis Inc. Common Stock | 30.86 Million USD | -1009.793% |
| Equillium, Inc. | 384 Thousand USD | -89088.021% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -5460.675% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -126.736% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -600.673% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -284585.209% |
| Dominari Holdings Inc. | 3.02 Million USD | -11210.502% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -1731968.983% |
| vTv Therapeutics Inc. | 169 Thousand USD | -202552.071% |
| Bio-Techne Corporation | 319 Million USD | -7.361% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -500.972% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -91.796% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -2122.899% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -2665.743% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -7024.652% |
| Nkarta, Inc. | 82.27 Million USD | -316.29% |
| BioCardia, Inc. | 982 Thousand USD | -34775.967% |
| Iterum Therapeutics plc | 18.95 Million USD | -1706.721% |